C137H131ClF8N16O11S5 — CID 167659261
N-(2-chlorophenyl)-3-[2-(3-fluorophenyl)-5-propanoylbenzimidazol-1-yl]piperidine-1-carboxamide;1-[2-(3,6-difluoro-2-hydroxyphenyl)-6-fluoro-1-[(1S,3R)-3-[2-(5-methylthiophen-2-yl)-2-oxoethyl]cyclohexyl]benzimidazol-5-yl]propan-1-one;1-[6-fluoro-2-(3-fluorothiophen-2-yl)-1-[(1S,3R)-3-[2-(5-methylthiophen-2-yl)-2-oxoethyl]cyclohexyl]benzimidazol-5-yl]propan-1-one;3-[2-(3-fluorophenyl)-5-propanoylbenzimidazol-1-yl]-N-(5-methylthiophen-2-yl)piperidine-1-carboxamide;3-[2-(3-fluorophenyl)-5-propanoylbenzimidazol-1-yl]-N-thiophen-2-ylpiperidine-1-carboxamide (PubChem CID 167659261) has the molecular formula C137H131ClF8N16O11S5 and a molecular weight of 2525.43 g/mol. Its IUPAC name is N-(2-chlorophenyl)-3-[2-(3-fluorophenyl)-5-propanoylbenzimidazol-1-yl]piperidine-1-carboxamide;1-[2-(3,6-difluoro-2-hydroxyphenyl)-6-fluoro-1-[(1S,3R)-3-[2-(5-methylthiophen-2-yl)-2-oxoethyl]cyclohexyl]benzimidazol-5-yl]propan-1-one;1-[6-fluoro-2-(3-fluorothiophen-2-yl)-1-[(1S,3R)-3-[2-(5-methylthiophen-2-yl)-2-oxoethyl]cyclohexyl]benzimidazol-5-yl]propan-1-one;3-[2-(3-fluorophenyl)-5-propanoylbenzimidazol-1-yl]-N-(5-methylthiophen-2-yl)piperidine-1-carboxamide;3-[2-(3-fluorophenyl)-5-propanoylbenzimidazol-1-yl]-N-thiophen-2-ylpiperidine-1-carboxamide.
| Compound Name | N-(2-chlorophenyl)-3-[2-(3-fluorophenyl)-5-propanoylbenzimidazol-1-yl]piperidine-1-carboxamide;1-[2-(3,6-difluoro-2-hydroxyphenyl)-6-fluoro-1-[(1S,3R)-3-[2-(5-methylthiophen-2-yl)-2-oxoethyl]cyclohexyl]benzimidazol-5-yl]propan-1-one;1-[6-fluoro-2-(3-fluorothiophen-2-yl)-1-[(1S,3R)-3-[2-(5-methylthiophen-2-yl)-2-oxoethyl]cyclohexyl]benzimidazol-5-yl]propan-1-one;3-[2-(3-fluorophenyl)-5-propanoylbenzimidazol-1-yl]-N-(5-methylthiophen-2-yl)piperidine-1-carboxamide;3-[2-(3-fluorophenyl)-5-propanoylbenzimidazol-1-yl]-N-thiophen-2-ylpiperidine-1-carboxamide |
|---|---|
| PubChem CID | 167659261 |
| Molecular Formula | C137H131ClF8N16O11S5 |
| Molecular Weight | 2525.43 g/mol |
| Exact Mass | 2522.83 |
| IUPAC Name | N-(2-chlorophenyl)-3-[2-(3-fluorophenyl)-5-propanoylbenzimidazol-1-yl]piperidine-1-carboxamide;1-[2-(3,6-difluoro-2-hydroxyphenyl)-6-fluoro-1-[(1S,3R)-3-[2-(5-methylthiophen-2-yl)-2-oxoethyl]cyclohexyl]benzimidazol-5-yl]propan-1-one;1-[6-fluoro-2-(3-fluorothiophen-2-yl)-1-[(1S,3R)-3-[2-(5-methylthiophen-2-yl)-2-oxoethyl]cyclohexyl]benzimidazol-5-yl]propan-1-one;3-[2-(3-fluorophenyl)-5-propanoylbenzimidazol-1-yl]-N-(5-methylthiophen-2-yl)piperidine-1-carboxamide;3-[2-(3-fluorophenyl)-5-propanoylbenzimidazol-1-yl]-N-thiophen-2-ylpiperidine-1-carboxamide |
| SMILES | CCC(=O)c1cc2nc(-c3c(F)ccc(F)c3O)n([C@H]3CCC[C@@H](CC(=O)c4ccc(C)s4)C3)c2cc1F.CCC(=O)c1cc2nc(-c3sccc3F)n([C@H]3CCC[C@@H](CC(=O)c4ccc(C)s4)C3)c2cc1F.CCC(=O)c1ccc2c(c1)nc(-c1cccc(F)c1)n2C1CCCN(C(=O)Nc2ccc(C)s2)C1.CCC(=O)c1ccc2c(c1)nc(-c1cccc(F)c1)n2C1CCCN(C(=O)Nc2ccccc2Cl)C1.CCC(=O)c1ccc2c(c1)nc(-c1cccc(F)c1)n2C1CCCN(C(=O)Nc2cccs2)C1 |
| InChI | InChI=1S/C29H27F3N2O3S.C28H26ClFN4O2.C27H26F2N2O2S2.C27H27FN4O2S.C26H25FN4O2S/c1-3-24(35)18-13-22-23(14-21(18)32)34(29(33-22)27-19(30)8-9-20(31)28(27)37)17-6-4-5-16(11-17)12-25(36)26-10-7-15(2)38-26;1-2-26(35)18-12-13-25-24(16-18)31-27(19-7-5-8-20(30)15-19)34(25)21-9-6-14-33(17-21)28(36)32-23-11-4-3-10-22(23)29;1-3-23(32)18-13-21-22(14-20(18)29)31(27(30-21)26-19(28)9-10-34-26)17-6-4-5-16(11-17)12-24(33)25-8-7-15(2)35-25;1-3-24(33)18-10-11-23-22(15-18)29-26(19-6-4-7-20(28)14-19)32(23)21-8-5-13-31(16-21)27(34)30-25-12-9-17(2)35-25;1-2-23(32)17-10-11-22-21(15-17)28-25(18-6-3-7-19(27)14-18)31(22)20-8-4-12-30(16-20)26(33)29-24-9-5-13-34-24/h7-10,13-14,16-17,37H,3-6,11-12H2,1-2H3;3-5,7-8,10-13,15-16,21H,2,6,9,14,17H2,1H3,(H,32,36);7-10,13-14,16-17H,3-6,11-12H2,1-2H3;4,6-7,9-12,14-15,21H,3,5,8,13,16H2,1-2H3,(H,30,34);3,5-7,9-11,13-15,20H,2,4,8,12,16H2,1H3,(H,29,33)/t16-,17+;;16-,17+;;/m1.1../s1 |
| InChIKey | RSGWUZVSBUMSEQ-FURVXXQHSA-N |
| XLogP | 35.80 |
| TPSA | 325.84 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 26 |
| Rotatable Bonds | 29 |
| Heavy Atoms | 178 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2525.43 |
| LogP ≤ 5 | 35.80 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 26 |